Literature DB >> 33619218

Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions.

Jeehoon Ham1,2,3, Bin Wang2,4,5, Joseph William Po1,3,4,6, Amandeep Singh2,7,8, Navin Niles3,7,8,9, Cheok Soon Lee10,2,3,5,9,11,12.   

Abstract

In 1989, Stephen Paget proposed the 'seed and soil' theory of cancer metastasis. This theory has led to previous researchers focusing on the role of a tumour as a cancer seed and antiangiogenesis agents as cancer soil fumigant; for the latter to be effective, it is important for them to be able to distinguish cancer cells from stromal cells. However, antiangiogenesis agents have not produced dramatic survival benefits in vivo. This may be related to their inability to destroy the supporting stroma that promote cancer cell growth. Therefore, in order to effectively arrest cancer cell growth for therapeutic purposes, a paradigm shift is required in our fundamental approach to decipher the molecular events and networks in the stromal environment that cancer cells can thrive and proliferate. The pathogenesis of cancer is a multidimensional process of pathological molecular and cellular pathways, influencing different stromal properties and achieving a mutually negotiated crosstalk between cancer cells and stromal cells. This review summarises the clinical presentation of current knowledge of classical papillary thyroid carcinoma (PTC), emerging molecular diagnostics and future directions of classical PTC research. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetics; molecular pathology; thyroid neoplasms

Year:  2021        PMID: 33619218     DOI: 10.1136/jclinpath-2020-207357

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  1 in total

1.  Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression.

Authors:  Ting Yan; Wangwang Qiu; Huaiyu Weng; Youben Fan; Guangwen Zhou; Zhili Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-01       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.